Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

DHRS4L2 Inhibitors

DHRS4L2 inhibitors encompass a variety of chemical compounds that act through distinct biochemical mechanisms to diminish the functional activity of this enzyme. Some inhibitors target the enzyme's cofactor availability, for instance, by impacting the synthesis or regeneration of essential cofactors that DHRS4L2 relies on for its catalytic function, thereby indirectly reducing its activity. Others act by competitively inhibiting the enzyme, where the inhibitor molecules resemble the natural substrates of DHRS4L2 closely enough to compete for binding, thus preventing the enzyme from interacting with its true substrates. This competition can be due to either synthetic retinoids or endogenous retinoid analogs that mimic the structure of the retinoids DHRS4L2 is meant to reduce.

Further mechanisms of DHRS4L2 inhibition involve the modulation of metabolic processes that indirectly influence the enzyme's activity. Some compounds disrupt the metabolic balance of alcohols and aldehydes, which are related to the substrates and products of DHRS4L2, thereby affecting its function. Others may alter the enzyme's substrate availability by influencing the absorption and bioavailability of retinoids, which are key for DHRS4L2's action. Additionally, there are chemicals that can affect retinoid signaling and metabolism, potentially leading to a decrease in DHRS4L2's enzymatic activity through complex feedback and regulatory pathways that govern retinoid homeostasis.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Targets and inhibits dihydrofolate reductase, leading to decreased production of tetrahydrofolate, a cofactor DHRS4L2 requires for the reduction of retinoids, thereby indirectly inhibiting DHRS4L2 activity.

13-cis-Retinoic acid

4759-48-2sc-205568
sc-205568A
100 mg
250 mg
$74.00
$118.00
8
(1)

A retinoid that competitively inhibits retinol dehydrogenases, potentially reducing DHRS4L2 activity by substrate competition.

Citral

5392-40-5sc-252620
1 kg
$212.00
(1)

Alters retinoid metabolism by modulating retinol dehydrogenase activity, which could indirectly decrease DHRS4L2 function by altering the substrate availability.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Inhibits aldehyde dehydrogenase, and by altering aldehyde metabolism, it could indirectly affect DHRS4L2 activity due to metabolic interplay.

Fomepizole

7554-65-6sc-252838
1 g
$74.00
1
(1)

Inhibits alcohol dehydrogenase and could indirectly decrease DHRS4L2 activity by modulating the balance of alcohols and aldehydes, which are related to the substrates and products of DHRS4L2.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

A retinoid that could compete with the natural substrates of DHRS4L2, potentially inhibiting its enzymatic activity through substrate competition.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

Can disrupt endogenous steroid hormone synthesis, potentially affecting the retinoid metabolism and thereby indirectly influencing DHRS4L2 function.

Omeprazole

73590-58-6sc-202265
50 mg
$66.00
4
(1)

Proton pump inhibitor which could alter gastric pH and consequently affect the absorption and bioavailability of retinoids, indirectly reducing DHRS4L2 activity.

Acitretin

55079-83-9sc-210754
25 mg
$148.00
1
(1)

A synthetic retinoid that could inhibit DHRS4L2 by competing with its natural substrates for retinoid binding and reduction.

4-Hydroxyphenylretinamide

65646-68-6sc-200900
sc-200900A
5 mg
25 mg
$104.00
$315.00
(0)

A synthetic retinoid that can modulate retinoid signaling and metabolism, potentially decreasing the functional activity of DHRS4L2 through substrate competition.